Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2578 maintenance anemia study in hemodialysis patients with chronic kidney disease
2009-010904-27Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2009
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of MK2578 in Uraemic Anaemia (2 arms), sponsored by Merck & Co. Primary endpoint: Change from baseline hemoglobin at Week 4. Started Jul 2009; status: terminated.
02
Drugs
MK2578
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2009-010904-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010904-27.